S. TÜRK Et Al. , "NK cell dysfunction of acute myeloid leukemia in relation to the RAS," COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs , Badalona, Spain, 2023
TÜRK, S. Et Al. 2023. NK cell dysfunction of acute myeloid leukemia in relation to the RAS. COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs , (Badalona, Spain).
TÜRK, S., YILMAZ, A., TÜRK, C., & UÇAR, G., (2023). NK cell dysfunction of acute myeloid leukemia in relation to the RAS . COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs, Badalona, Spain
TÜRK, SEYHAN Et Al. "NK cell dysfunction of acute myeloid leukemia in relation to the RAS," COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs, Badalona, Spain, 2023
TÜRK, SEYHAN Et Al. "NK cell dysfunction of acute myeloid leukemia in relation to the RAS." COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs , Badalona, Spain, 2023
TÜRK, S. Et Al. (2023) . "NK cell dysfunction of acute myeloid leukemia in relation to the RAS." COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs , Badalona, Spain.
@conferencepaper{conferencepaper, author={SEYHAN TÜRK Et Al. }, title={NK cell dysfunction of acute myeloid leukemia in relation to the RAS}, congress name={COST Action CA21135 - 1st IMMUNO-model COST Action Conference Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs}, city={Badalona}, country={Spain}, year={2023}}